微创与开放远端胰腺切除术(LEOPARD):随机对照试验研究方案
LEOPARD 是一项在荷兰胰腺癌协作组全部 17 个中心开展的随机对照、平行组、患者盲法、多中心优效性试验,计划纳入 102 例有症状的良性、癌前或恶性疾病患者,随机接受微创远端胰腺切除术(MIDP)或开放远端胰腺切除术(ODP),主要结局为功能恢复时间(天)。
要点
- 观察性队列提示 MIDP 短期结局优于 ODP,但病例匹配研究未能证实其优效性。
- LEOPARD 在加速康复背景下比较 MIDP 与 ODP 的功能恢复时间。
- 计划纳入 102 例有症状良性、癌前或恶性疾病患者,在荷兰 17 个中心随机分组。
核心结论
- LEOPARD 试验旨在研究在加速康复背景下 MIDP 是否较 ODP 缩短功能恢复时间。
研究设计与样本
- 随机对照、平行组、患者盲法、多中心优效性试验,在荷兰胰腺癌协作组全部 17 个中心开展。
- 计划纳入 102 例有症状的良性、癌前或恶性疾病患者,随机分配至 MIDP 或 ODP,均在加速康复背景下。
主要发现
- 观察性队列研究提示 MIDP 较 ODP 短期结局更好,如术中失血更少、并发症发生率更低、住院时间更短和总费用更低。
- 病例匹配研究未能证实 MIDP 的优效性,提示适应证混杂可能影响了观察性 findings。
- 目前缺乏多中心随机对照试验。
关键数值与推荐
- 主要结局为功能恢复时间(天),功能恢复定义为同时满足以下全部条件:独立活动达到术前水平、仅用口服药物即可充分控制疼痛、能够维持足够的(即 >50%)每日所需热量摄入、无需静脉输液且无感染迹象。
- 次要结局为手术和术后结局,包括临床相关并发症、死亡率、生活质量和费用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Observational cohort studies have suggested that minimally invasive distal pancreatectomy (MIDP) is associated with better short-term outcomes compared with open distal pancreatectomy (ODP), such as less intraoperative blood loss, lower morbidity, shorter length of hospital stay, and reduced total costs. Confounding by indication has probably influenced these findings, given that case-matched studies failed to confirm the superiority of MIDP. This accentuates the need for multicenter randomized controlled trials, which are currently lacking. We hypothesize that time to functional recovery is shorter after MIDP compared with ODP even in an enhanced recovery setting. METHODS: LEOPARD is a randomized controlled, parallel-group, patient-blinded, multicenter, superiority trial in all 17 centers of the Dutch Pancreatic Cancer Group. A total of 102 patients with symptomatic benign, premalignant or malignant disease will be randomly allocated to undergo MIDP or ODP in an enhanced recovery setting. The primary outcome is time (days) to functional recovery, defined as all of the following: independently mobile at the preoperative level, sufficient pain control with oral medication alone, ability to maintain sufficient (i.e. >50%) daily required caloric intake, no intravenous fluid administration and no signs of infection. Secondary outcomes are operative and postoperative outcomes, including clinically relevant complications, mortality, quality of life and costs. DISCUSSION: The LEOPARD trial is designed to investigate whether MIDP reduces the time to functional recovery compared with ODP in an enhanced recovery setting. TRIAL REGISTRATION: Dutch Trial Register, NTR5188 . Registered on 9 April 2015.
引用
- de Rooij T, van Hilst J, Vogel JA, et al. Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trial. Trials. 2017. PMID: 28388963. doi:10.1186/s13063-017-1892-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。